focus -WSS

focus

author：leisure time 2025-10-02 17:22:03 - browse：2

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Stem cell clinics for heart failure: buyer be wary

focus

Wikipedia

WSS

What Henrietta Lacks settlement says about racism in medicine

White House drug shortage group privately met with industry

NIH director takes cautious approach to Biden drug pricing priority

TytoCare raises $49 million to build out AI

Test for long Covid? Researchers find new clue in blood samples

EU regulator recommends expanding Mounjaro approval to obesity

focus

focus

hotspot

In age of alternative facts, a scholarly course on calling out crap

A cyberattack has disrupted hospitals and health care in several states

State Dept. review finds Biden bears some blame for Afghanistan failures

ProMED, early warning system on disease outbreaks, in peril

State Dept. review finds Biden bears some blame for Afghanistan failures

Parkinson’s finding may lead to tests and, someday, treatments

At least 13 dead in Texas as scorching temps continue

Biden calls for immediate release of Niger's president amid apparent coup

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Test for long Covid? Researchers find new clue in blood samples

leisure time

White House drug shortage group privately met with industry

Parkinson’s finding may lead to tests and, someday, treatments

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Dramatically reducing cancer deaths requires the PASTEUR Act

Stem cell clinics for heart failure: buyer be wary

Think you might have Covid

focus

focus

Wikipedia

Wikipedia